Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Narayanan

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|February 9, 2020
Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?Esraa Shosha, Abdelrahman Y Fouda, S Priya Narayanan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 20, 2023
Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathyShengshuai Shan, Fang Liu, Edith Ford, et al.
Physiological Reviews|February 8, 2018
Arginase: A Multifaceted Enzyme Important in Health and DiseaseR William Caldwell, Paulo C Rodriguez, Haroldo A Toque, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 17, 2009
Fistulas in malignant gynecologic disease: etiology, imaging, and managementPriya Narayanan, Marielle Nobbenhuis, Karina M Reynolds, et al.
European Radiology|July 21, 2012
The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patternsYen Zhi Tang, Sid Liyanage, Priya Narayanan, et al.
ASN Neuro|October 8, 2014
A new model of cuprizone-mediated demyelination/remyelinationHilary H Sachs, Kathryn K Bercury, Daniela C Popescu, et al.
Progress in Retinal and Eye Research|July 9, 2013
Arginase in retinopathyS Priya Narayanan, Modesto Rojas, Jutamas Suwanpradid, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvantJan Ole Kemnade, Mamatha Seethammagari, Priya Narayanan, et al.
Cells|September 13, 2025
Claudin 5 Across the Vascular Landscape: From Blood-Tissue Barrier Regulation to Disease MechanismsMohamed S Selim, Bayan R Matani, Harry O Henry-Ojo, et al.
International Journal of Molecular Sciences|May 7, 2025
Claudin-17 Deficiency Drives Vascular Permeability and Inflammation Causing Lung InjuryMir S Adil, Varun Parvathagiri, Abdulaziz H Alanazi, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|February 9, 2020
Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?Esraa Shosha, Abdelrahman Y Fouda, S Priya Narayanan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 20, 2023
Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathyShengshuai Shan, Fang Liu, Edith Ford, et al.
Physiological Reviews|February 8, 2018
Arginase: A Multifaceted Enzyme Important in Health and DiseaseR William Caldwell, Paulo C Rodriguez, Haroldo A Toque, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 17, 2009
Fistulas in malignant gynecologic disease: etiology, imaging, and managementPriya Narayanan, Marielle Nobbenhuis, Karina M Reynolds, et al.
European Radiology|July 21, 2012
The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patternsYen Zhi Tang, Sid Liyanage, Priya Narayanan, et al.
ASN Neuro|October 8, 2014
A new model of cuprizone-mediated demyelination/remyelinationHilary H Sachs, Kathryn K Bercury, Daniela C Popescu, et al.
Progress in Retinal and Eye Research|July 9, 2013
Arginase in retinopathyS Priya Narayanan, Modesto Rojas, Jutamas Suwanpradid, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvantJan Ole Kemnade, Mamatha Seethammagari, Priya Narayanan, et al.
Cells|September 13, 2025
Claudin 5 Across the Vascular Landscape: From Blood-Tissue Barrier Regulation to Disease MechanismsMohamed S Selim, Bayan R Matani, Harry O Henry-Ojo, et al.
International Journal of Molecular Sciences|May 7, 2025
Claudin-17 Deficiency Drives Vascular Permeability and Inflammation Causing Lung InjuryMir S Adil, Varun Parvathagiri, Abdulaziz H Alanazi, et al.
Pageof 10